The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1700
April 15, 2024
View Complete Issue         Table of Contents 2019 
Cabtreo: A Three-Drug Gel for Acne
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Cabtreo: A Three-Drug Gel for Acne
April 15, 2024 (Issue: 1700)
The FDA has approved Cabtreo (Bausch Health), a gel containing the retinoid adapalene, the oxidizing agent benzoyl peroxide, and the antibiotic clindamycin, for treatment of acne vulgaris in patients ≥12 years old. Cabtreo is the first...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Cabtreo: A Three-Drug Gel for Acne
Article code: 1700b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.